Background: Asthma is a chronic inflammatory disorder that causes shortness of
breath, wheezing and chest tightness. It affected 262 million people globally in
2019 and resulted in 455,000 deaths. In Europe, only 6% of the population was
affected. Various treatments, including SABA (Short-Acting Beta Agonists) for
adult asthma patients and inhaled corticosteroids for maintenance are used to
manage and prevent the worsening of asthma. Methodology: This review
examines the impact of educational interventions on the quality of life of asthma
patients in Europe. It uses electronic databases such as Science Direct, PubMed,
ProQuest and Google Scholar for manual searching and follows preferred
Reporting Items for Systematic Reviews and Meta-Analysis (PRISMA)
guidelines. From the pool of 22269 studies, 30 studies met inclusion criteria.
These studies specifically focused on assessing the quality of life among asthma
patients. Results: The studies show that asthma patients' quality of life
significantly improved after intervention, with pharmacist led interventional
programs and physician guidelines played a significant role. Stress management
and smoking cessation are essential for managing asthma symptoms, but anxiety
and depression are major co-founders. Conclusion: The review reveals that
educational interventions significantly enhance the quality of life for asthma
patients, providing valuable insights for healthcare providers in both
pharmacological and non-pharmacological asthma management.
Keywords: Asthma, Intervention, Quality of Life, European Countries